title: Indirubin-3'-monoxime, a derivative of a Chinese anti-leukemia medicine, inhibits Notch1 signaling.
abstract: Notch proteins perform a critical function in cell-fate decisions and in differentiation. In this study, we determined that indirubin-3'-monoxime reduced Notch1 signaling to a remarkable extent. Indirubin-3'-monoxime has been shown to inhibit both constitutive active mutants of Notch1 and Notch1-IC-mediated transactivation activity. However, in such cases, neither the Notch cleavage pattern nor the protein stability of Notch1-IC was determined to have been significantly altered. Indirubin-3'-monoxime suppresses Notch1 transcriptional activity via the dissociation of the Notch1-IC-RBP-Jk complex. Notably, the transcriptional activity of Notch1-IC was not suppressed significantly in the GSK-3beta null cells by indirubin-3'-monoxime as compared to what was observed with GSK-3beta wild-type cells. In the previous study, we synthesized a series of indirubin derivatives. Interestingly, some of these indirubin derivatives were characterized as potent inhibitors of Notch1 signaling. Taken together, the results of this study indicate that indirubin-3'-monoxime downregulated Notch1 signaling in a GSK-3beta-dependent and proteosomal degradation-independent manner.
authors.affiliation: Hormone Research Center, School of Biological Sciences and Technology, Chonnam National University, Yongbong-dong, Gwangju, Republic of Korea.
authors.forename: Mi-Jee
authors.initials: MJ
authors.lastname: Lee
authors.forename: Mi-Yeon
authors.initials: MY
authors.lastname: Kim
authors.forename: Jung-Soon
authors.initials: JS
authors.lastname: Mo
authors.forename: Eun-Jung
authors.initials: EJ
authors.lastname: Ann
authors.forename: Mi-Sun
authors.initials: MS
authors.lastname: Seo
authors.forename: Ji-Ae
authors.initials: JA
authors.lastname: Hong
authors.forename: Yong-Chul
authors.initials: YC
authors.lastname: Kim
authors.forename: Hee-Sae
authors.initials: HS
authors.lastname: Park
mesh_terms: D015536:Down-Regulation; D053595:Embryonic Stem Cells / Q000187:drug effects / Q000378:metabolism*; D038362:Glycogen Synthase Kinase 3 / Q000378:metabolism; D006801:Humans; D007211:Indoles / Q000494:pharmacology*; D010091:Oximes / Q000494:pharmacology*; D017434:Protein Structure, Tertiary; D051880:Receptors, Notch / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects
chemical_list: D007211:Indoles; D010091:Oximes; D051880:Receptors, Notch; C474021:indirubin-3'-monoxime; D038362:Glycogen Synthase Kinase 3